American Diabetes Association

Skip to Main Content

TABLE 3

Markers of cardiovascular risks and oxidative stress at admission and resolution of hyperglycemic crisis

	Lean DKA			Obese DKA			Obese hyperglycemia			Lean control	Obese control
		Admission	Resolution	Admission	Resolution	Admission	Resolution			Lean control	Obese control
CRP (mg/l)	51 ± 3	28 ± 1^*^†	59 ± 13	34 ± 9^*^†	28 ± 6	13 ± 3^*^†	1 ± 0.2^*^†	2 ± 0.4^*^†
Homocysteine (μmol/l)	18.8 ± 0.8	14.8 ± 0.7^*^†	23.6 ± 3.6	21.6 ± 2.8	14.8 ± 1.6	12.4 ± 1.2^*	7.2 ± 0.4^*^†	8.8 ± 1.2^*^†
FFA (mmol/l)	1.6 ± 0.1	0.6 ± 0.1^*^†	1.4 ± 0.1	0.7 ± 0.1^*^†	1.2 ± 0.2	0.8 ± 0.1^*^†	0.5 ± 0.1^*^†	0.7 ± 0.1^*^†
DCF (μmol/l)	8.6 ± 0.8	3.7 ± 0.5^*^†	8.9 ± 1.2	4.1 ± 0.7^*^†	7.8 ± 0.6	3.8 ± 0.5^*^†	2.3 ± 0.4^*^†	3.1 ± 0.6^*^†
TBA (μmol/l)	3.8 ± 0.7	1.3 ± 0.4^*^†	4.0 ± 0.6	1.6 ± 0.2^*^†	3.3 ± 0.5	1.5 ± 0.4^*^†	0.8 ± 0.1^*^†	0.9 ± 0.1^*^†
PAI-1 (ng/ml)	42.1 ± 12.2	4.2 ± 2.1^*^†	40.4 ± 12.4	13.0 ± 3.4^*^†	35.4 ± 9.3	7.3 ± 2.4^*^†	1.4 ± 0.2^*^†	2.5 ± 0.4^*^†

	Lean DKA			Obese DKA			Obese hyperglycemia			Lean control	Obese control
		Admission	Resolution	Admission	Resolution	Admission	Resolution			Lean control	Obese control
CRP (mg/l)	51 ± 3	28 ± 1^*^†	59 ± 13	34 ± 9^*^†	28 ± 6	13 ± 3^*^†	1 ± 0.2^*^†	2 ± 0.4^*^†
Homocysteine (μmol/l)	18.8 ± 0.8	14.8 ± 0.7^*^†	23.6 ± 3.6	21.6 ± 2.8	14.8 ± 1.6	12.4 ± 1.2^*	7.2 ± 0.4^*^†	8.8 ± 1.2^*^†
FFA (mmol/l)	1.6 ± 0.1	0.6 ± 0.1^*^†	1.4 ± 0.1	0.7 ± 0.1^*^†	1.2 ± 0.2	0.8 ± 0.1^*^†	0.5 ± 0.1^*^†	0.7 ± 0.1^*^†
DCF (μmol/l)	8.6 ± 0.8	3.7 ± 0.5^*^†	8.9 ± 1.2	4.1 ± 0.7^*^†	7.8 ± 0.6	3.8 ± 0.5^*^†	2.3 ± 0.4^*^†	3.1 ± 0.6^*^†
TBA (μmol/l)	3.8 ± 0.7	1.3 ± 0.4^*^†	4.0 ± 0.6	1.6 ± 0.2^*^†	3.3 ± 0.5	1.5 ± 0.4^*^†	0.8 ± 0.1^*^†	0.9 ± 0.1^*^†
PAI-1 (ng/ml)	42.1 ± 12.2	4.2 ± 2.1^*^†	40.4 ± 12.4	13.0 ± 3.4^*^†	35.4 ± 9.3	7.3 ± 2.4^*^†	1.4 ± 0.2^*^†	2.5 ± 0.4^*^†

Data are means ± SE.

*

P < 0.01 vs. lean DKA on admission;

†

P < 0.05 vs. admission value of each group.